Sudan ebolavirus and Marburg virus vaccine candidates: GeoVax announces multi-party collaboration
by Press Release from Outbreak News Today on (#56WK5)
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and cancer, announced today a multi-party collaboration for the development of Sudan ebolavirus (SUDV) and Marburg virus (MARV) vaccine candidates. SUDV and MARV cause viral hemorrhagic fevers. The collaboration between GeoVax, researchers at the University of Texas Medical Branch (UTMB), and [...]
The post Sudan ebolavirus and Marburg virus vaccine candidates: GeoVax announces multi-party collaboration appeared first on Outbreak News Today.